A delay in drug approvals in the US market remains a concern for Aurobindo. The company stated that eight ANDAs (abbreviated ...
6d
ET Now on MSNAurobindo's CuraTeq Biologics Aims Doubling Down on Biosimilar Launches - 2031 Plans REVEALED | ET NOW On The Go Hyderabad EditionAurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its subsidiary Theranym Biologics, has agreed on a contract to roll out a single ...
Hyderabad: Nearly a year and a half after its subsidiary, Auro Vaccines Pvt Ltd, inked a licensing pact with Hilleman ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Aurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for developing a pentavalent vaccine for children. The company asserted that this ...
Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent ...
The university will again approach the state government so 35 additional contractual security guards could be appointed by ...
Explore the deep historical, spiritual, and cultural ties between India and France at an international conference in ...
Minister advises parents at school event; judges and police commissioner present prizes; entrepreneurship session at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results